Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel Free ALMS Stock Alerts

Alumis (ALMS) Financials

Alumis logo
$28.66 +1.43 (+5.25%)
Closing price 07/17/2026 04:00 PM Eastern
Extended Trading
$28.68 +0.02 (+0.09%)
As of 07/17/2026 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Alumis

Annual Income Statements for Alumis

This table shows Alumis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -155 -294 -243
Consolidated Net Income / (Loss)		 -155 -294 -243
Net Income / (Loss) Continuing Operations		 -155 -294 -243
Total Pre-Tax Income 		-155 -294 -252
Total Operating Income		 -158 -301 -454
Total Gross Profit		 0.00 0.00 24
Total Revenue		 0.00 0.00 24
Operating Revenue		 - 0.00 24
Total Cost of Revenue		 0.00 0.00 0.00
Total Operating Expenses		 158 301 478
Selling, General & Admin Expense		 20 35 92
Research & Development Expense		 138 266 386
Total Other Income / (Expense), net		 3.18 6.52 202
Interest & Investment Income		 3.37 12 14
Other Income / (Expense), net		 -0.19 -5.50 188
Income Tax Expense		 - 0.00 -8.56
Basic Earnings per Share		 ($72.08) ($10.38) ($2.86)
Weighted Average Basic Shares Outstanding		 2.15M 28.34M 85.03M
Diluted Earnings per Share		 ($72.08) ($10.38) ($2.86)
Weighted Average Diluted Shares Outstanding		 2.15M 28.34M 85.03M
Weighted Average Basic & Diluted Shares Outstanding		 - 54.41M 127.20M

Quarterly Income Statements for Alumis

This table shows Alumis' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -36 -43 -50 -57 -93 -95 -99 59 -111 -93 -93
Consolidated Net Income / (Loss)		 -36 -43 -50 -57 -93 -95 -99 59 -111 -93 -93
Net Income / (Loss) Continuing Operations		 -36 -43 -50 -57 -93 -95 -99 59 -111 -93 -93
Total Pre-Tax Income 		-36 -43 -50 -57 -93 -95 -99 51 -111 -93 -93
Total Operating Income		 -38 -44 -48 -56 -98 -99 -102 -141 -115 -96 -98
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00 - 17 2.67 2.07 1.93 1.74
Total Revenue		 0.00 0.00 0.00 0.00 0.00 - 17 2.67 2.07 1.93 1.74
Operating Revenue		 - - 0.00 0.00 0.00 - 17 2.67 2.07 1.93 1.74
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses		 38 44 48 56 98 99 119 143 117 98 100
Selling, General & Admin Expense		 4.78 5.97 5.63 7.58 11 11 22 34 20 16 19
Research & Development Expense		 33 38 42 49 88 87 97 109 98 83 82
Total Other Income / (Expense), net		 1.33 0.38 -2.26 -0.37 5.28 3.86 2.57 191 4.54 3.51 5.36
Interest & Investment Income		 0.91 - 0.85 1.98 5.32 3.87 2.61 3.43 4.59 3.55 5.35
Other Income / (Expense), net		 0.42 0.38 -3.11 -2.35 -0.04 -0.00 -0.04 188 -0.05 -0.03 0.01
Basic Earnings per Share		 ($34.26) ($19.76) ($21.03) ($23.10) ($1.73) $35.48 ($1.82) $0.78 ($1.06) ($0.76) ($0.74)
Weighted Average Basic Shares Outstanding		 4.24M 2.19M 2.37M 2.45M 53.75M 28.34M 54.28M 76.48M 104.11M 85.03M 125.05M
Diluted Earnings per Share		 ($34.26) ($19.76) ($21.03) ($23.10) ($1.73) $35.48 ($1.82) $0.77 ($1.06) ($0.75) ($0.74)
Weighted Average Diluted Shares Outstanding		 4.24M 2.19M 2.37M 2.45M 53.75M 28.34M 54.28M 76.64M 104.11M 85.03M 125.05M
Weighted Average Basic & Diluted Shares Outstanding		 - - - 54.40M 54.41M 54.41M 54.41M 104.06M 104.39M 127.20M 127.49M

Annual Cash Flow Statements for Alumis

This table details how cash moves in and out of Alumis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 20 123 -80
Net Cash From Operating Activities		 -130 -255 -370
Net Cash From Continuing Operating Activities		 -130 -255 -370
Net Income / (Loss) Continuing Operations		 -155 -294 -243
Consolidated Net Income / (Loss)		 -155 -294 -243
Depreciation Expense		 1.28 3.15 3.50
Non-Cash Adjustments To Reconcile Net Income		 22 26 -117
Changes in Operating Assets and Liabilities, net		 1.36 10 -13
Net Cash From Investing Activities		 60 -114 288
Net Cash From Continuing Investing Activities		 60 -114 288
Purchase of Property, Plant & Equipment		 -4.50 -1.73 -0.65
Acquisitions		 - 0.00 50
Purchase of Investments		 -11 -240 -209
Sale and/or Maturity of Investments		 76 128 448
Net Cash From Financing Activities		 90 492 2.07
Net Cash From Continuing Financing Activities		 90 492 2.07
Repurchase of Common Equity		 -0.55 -0.01 -0.02
Issuance of Preferred Equity		 90 258 0.00
Issuance of Common Equity		 0.00 233 1.60
Other Financing Activities, net		 0.45 0.60 0.49

Quarterly Cash Flow Statements for Alumis

This table details how cash moves in and out of Alumis' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -26 -8.15 66 43 58 -44 -41 24 -87 24 -26
Net Cash From Operating Activities		 -33 -34 -44 -52 -84 -75 -80 -106 -111 -72 -87
Net Cash From Continuing Operating Activities		 -34 -33 -44 -52 -84 -75 -80 -106 -111 -72 -87
Net Income / (Loss) Continuing Operations		 -43 -39 -50 -57 -93 -95 -99 59 -111 -93 -93
Consolidated Net Income / (Loss)		 -43 -39 -50 -57 -93 -95 -99 59 -111 -93 -93
Depreciation Expense		 0.32 0.73 0.76 0.76 0.81 0.82 0.84 0.87 0.92 0.87 0.87
Non-Cash Adjustments To Reconcile Net Income		 6.72 6.93 3.00 0.43 10 15 13 -158 18 10 13
Changes in Operating Assets and Liabilities, net		 2.64 -1.54 1.83 3.04 -1.83 4.66 4.79 -8.86 -19 9.85 -7.82
Net Cash From Investing Activities		 7.58 -4.14 -19 -33 -93 31 39 129 24 95 -286
Net Cash From Continuing Investing Activities		 7.58 -4.14 -19 -33 -93 31 39 129 24 95 -286
Purchase of Property, Plant & Equipment		 -2.17 -1.21 -0.16 -0.43 -0.78 -0.37 -0.04 -0.62 - - -0.16
Purchase of Investments		 -0.01 -2.93 -20 -39 -126 -55 -25 - -137 -48 -428
Sale and/or Maturity of Investments		 9.75 - 1.00 7.00 34 86 64 80 161 143 143
Net Cash From Financing Activities		 0.05 30 129 128 235 0.01 0.00 0.75 - 1.32 347
Net Cash From Continuing Financing Activities		 0.05 30 129 128 235 0.01 0.00 0.75 - 1.32 347
Issuance of Common Equity		 - 0.01 - - - - 0.00 - - 0.83 324
Other Financing Activities, net		 0.07 0.21 0.03 0.51 0.05 0.01 0.00 - - 0.49 23

Annual Balance Sheets for Alumis

This table presents Alumis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets		 90 341 412
Total Current Assets		 53 306 318
Cash & Equivalents		 46 170 90
Restricted Cash		 0.11 0.00 0.08
Short-Term Investments		 2.96 119 219
Prepaid Expenses		 4.29 18 9.65
Plant, Property, & Equipment, net		 22 21 18
Total Noncurrent Assets		 14 14 76
Long-Term Investments		 - - 0.00
Intangible Assets		 - 0.00 51
Other Noncurrent Operating Assets		 14 14 25
Total Liabilities & Shareholders' Equity		 90 341 412
Total Liabilities		 54 81 111
Total Current Liabilities		 21 51 73
Accounts Payable		 1.12 9.62 10
Accrued Expenses		 18 40 57
Current Deferred Revenue		 - 0.00 1.46
Other Current Liabilities		 1.72 1.56 4.67
Total Noncurrent Liabilities		 33 30 37
Noncurrent Deferred Revenue		 - 0.00 2.61
Noncurrent Deferred & Payable Income Tax Liabilities		 - 0.00 2.14
Other Noncurrent Operating Liabilities		 33 30 33
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -339 260 301
Total Preferred & Common Equity		 -339 260 301
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 -339 260 301
Common Stock		 25 919 1,203
Retained Earnings		 -364 -659 -902
Accumulated Other Comprehensive Income / (Loss)		 0.00 0.04 0.19

Quarterly Balance Sheets for Alumis

This table presents Alumis' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 265 413 261 611 488 672
Total Current Assets		 225 377 226 518 393 532
Cash & Equivalents		 155 213 129 152 65 64
Restricted Cash		 0.11 0.00 - 0.37 - 0.09
Short-Term Investments		 54 148 80 335 312 459
Prepaid Expenses		 15 15 17 31 16 9.38
Plant, Property, & Equipment, net		 22 21 20 20 19 18
Total Noncurrent Assets		 18 14 15 73 76 122
Long-Term Investments		 - - - - - 47
Intangible Assets		 - - - 51 51 51
Other Noncurrent Operating Assets		 18 14 15 22 25 24
Total Liabilities & Shareholders' Equity		 265 413 261 611 488 672
Total Liabilities		 65 64 93 126 103 105
Total Current Liabilities		 33 34 60 86 65 71
Accounts Payable		 9.19 6.44 7.47 15 4.55 12
Accrued Expenses		 23 26 50 67 56 49
Current Deferred Revenue		 - - - - - 6.33
Other Current Liabilities		 1.52 1.47 2.55 4.06 4.41 4.44
Total Noncurrent Liabilities		 31 31 33 40 38 34
Noncurrent Deferred Revenue		 - - 2.61 2.61 1.94 0.00
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - 2.14 2.14 2.14
Other Noncurrent Operating Liabilities		 31 31 30 35 34 32
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -439 348 168 485 385 567
Total Preferred & Common Equity		 -439 348 168 485 385 567
Preferred Stock		 - 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -439 348 168 485 385 567
Common Stock		 32 912 926 1,183 1,193 1,562
Retained Earnings		 -471 -564 -758 -698 -809 -995
Accumulated Other Comprehensive Income / (Loss)		 -0.00 0.14 -0.01 0.02 0.23 -0.47

Annual Metrics And Ratios for Alumis

This table displays calculated financial ratios and metrics derived from Alumis' official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - 104,393,403.00
DEI Adjusted Shares Outstanding		 - - 104,393,403.00
DEI Earnings Per Adjusted Shares Outstanding		 - - -2.33
Growth Metrics		 - - -
Profitability Metrics		 - - -
Net Operating Profit after Tax (NOPAT)		 -111 -211 -318
Return On Investment Capital (ROIC_SIMPLE)		 32.64% -80.94% -105.43%
Earnings before Interest and Taxes (EBIT)		 -158 -306 -266
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -157 -303 -263
Valuation Ratios		 - - -
Leverage & Solvency		 - - -
Liquidity Ratios		 - - -
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 0.00 -195 -339
Efficiency Ratios		 - - -
Capital & Investment Metrics		 - - -
Invested Capital		 -13 -28 -7.29
Increase / (Decrease) in Invested Capital		 0.00 -15 21
Book Value per Share		 ($157.78) $4.78 $2.89
Tangible Book Value per Share		 ($157.78) $4.78 $2.40
Total Capital		 36 260 301
Total Debt		 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00
Net Debt		 -49 -288 -309
Capital Expenditures (CapEx)		 4.50 1.73 0.65
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -17 -33 -64
Debt-free Net Working Capital (DFNWC)		 32 255 245
Net Working Capital (NWC)		 32 255 245
Net Nonoperating Expense (NNE)		 44 84 -74
Net Nonoperating Obligations (NNO)		 -49 -288 -309
Total Depreciation and Amortization (D&A)		 1.28 3.15 3.50
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 ($10.38) ($2.86)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 28.34M 85.03M
Adjusted Diluted Earnings per Share		 $0.00 ($10.38) ($2.86)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 28.34M 85.03M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 54.41M 127.20M
Normalized Net Operating Profit after Tax (NOPAT)		 -111 -211 -318
Debt Service Ratios		 - - -
Payout Ratios		 - - -

Quarterly Metrics And Ratios for Alumis

This table displays calculated financial ratios and metrics derived from Alumis' official financial filings.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - 0.00 - - 54,407,327.00 54,407,327.00 54,405,544.00 104,064,302.00 104,393,403.00 127,199,333.00
DEI Adjusted Shares Outstanding		 - - 0.00 - - 54,407,327.00 54,407,327.00 54,405,544.00 104,064,302.00 104,393,403.00 127,199,333.00
DEI Earnings Per Adjusted Shares Outstanding		 - - 0.00 - - -1.74 -1.82 1.09 -1.06 -0.89 -0.73
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -89.99%
EBITDA Growth		 0.00% 0.00% 0.00% -57.21% -126.72% - -101.68% 183.50% -17.21% - 3.17%
EBIT Growth		 0.00% 0.00% 0.00% -57.21% -126.94% - -100.33% 180.93% -17.18% - 3.12%
NOPAT Growth		 0.00% 0.00% 0.00% -49.22% -124.87% - -113.33% -317.94% -17.17% - 3.07%
Net Income Growth		 0.00% 0.00% 0.00% -55.72% -114.67% - -98.53% 204.98% -18.94% - 5.97%
EPS Growth		 0.00% 0.00% 0.00% -34.85% 91.24% - 91.35% 103.33% 38.73% - 59.34%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% 0.00% -151.96% - -81.54% -103.40% -32.40% - -8.37%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% -470.89% -82.74% - -248.33%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 85.15% 152.29% - 93.54%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% -84.67% -22.51% - -9.75%
EBITDA Q/Q Growth		 0.00% -15.74% 0.00% 0.00% -66.92% - 0.00% 147.85% -337.41% - -2.01%
EBIT Q/Q Growth		 0.00% -16.60% 0.00% 0.00% -68.32% - 0.00% 146.60% -343.71% - -1.99%
NOPAT Q/Q Growth		 0.00% -16.31% 0.00% 0.00% -75.27% - 0.00% -131.10% 50.86% - -2.04%
Net Income Q/Q Growth		 0.00% -19.53% 0.00% 0.00% -64.79% - 0.00% 159.94% -286.70% - -0.13%
EPS Q/Q Growth		 0.00% 42.32% 0.00% 0.00% 96.26% - 0.00% 142.31% -237.66% - 1.33%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -31.24% 0.00% 0.00% - -7.48% -32.35% -4.28% - -21.10%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% -83.83% - 0.00% -461.60% 41.16% - -20.73%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% -47.14% - 0.00% 96.63% 617.93% - 64.16%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% - 100.00% 100.00% 100.00% - 100.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% - -579.27% 1,807.95% -5,538.72% - -5,602.01%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% - -583.86% -5,271.53% -5,580.45% - -5,652.44%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% - -584.12% 1,775.32% -5,583.06% - -5,652.04%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% - -569.11% 2,225.09% -5,360.70% - -5,344.80%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00% 116.87% 100.00% - 100.00%
Interest Burden Percent		 97.55% 100.00% 98.32% 96.62% 94.59% - 97.43% 107.25% 96.02% - 94.56%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% -16.87% 0.00% - 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 0.00% 0.00% - -203.99% -66.35% -66.88% - -64.57%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% - -38.87% 81.28% -274.28% - -101.81%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% - -37.87% 101.87% -263.35% - -96.28%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 0.00% 0.00% - -203.99% -4.51% -66.88% - -64.57%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% - -203.99% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)		 -26 -31 -33 -39 -69 -69 -71 -164 -81 -68 -69
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% - -408.70% -6,160.61% -3,906.31% - -3,956.71%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% -16.42% -13.40% - -26.72% 64.21% -8.13% - -6.21%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -26.54% -42.22% -33.84% -20.97% -22.41% -12.15%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% - 128.21% 1,292.20% 944.92% - 1,068.93%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% - 555.65% 4,079.33% 4,735.53% - 4,683.52%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% - 683.86% 5,371.53% 5,680.45% - 5,752.44%
Earnings before Interest and Taxes (EBIT)		 -37 -43 -51 -58 -98 -99 -102 47 -115 -96 -98
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -37 -43 -50 -58 -98 -98 -101 48 -114 -96 -98
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 1.67 - 1.98 0.34 1.08 - 4.94
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 1.67 - 1.98 0.38 1.24 - 5.43
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 - 19.21 8.14 18.77 - 333.52
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 5.32 - 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 - 7.21 0.00 1.69 - 265.72
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Financial Leverage		 0.00 0.00 0.00 -1.05 -1.04 - -1.24 -1.02 -1.01 - -1.06
Leverage Ratio		 0.00 0.00 0.00 1.32 1.18 - 1.55 1.28 1.23 - 1.27
Compound Leverage Factor		 0.00 0.00 0.00 1.28 1.12 - 1.51 1.37 1.18 - 1.20
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 318.85% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital		 0.00% 0.00% 0.00% -218.85% 100.00% - 100.00% 100.00% 100.00% - 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Altman Z-Score		 0.00 0.00 0.00 0.00 0.00 - -2.36 0.32 0.16 - 14.36
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 93.21% 0.00% - 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 0.00 0.00 6.73 11.26 - 3.73 6.05 6.01 - 7.51
Quick Ratio		 0.00 0.00 0.00 6.27 10.80 - 3.45 5.68 5.77 - 7.38
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.00 -30 -55 0.00 -31 -172 -101 -88 -107
Operating Cash Flow to CapEx		 0.00% -1,532.78% -28,556.13% 0.00% -10,753.02% - -217,175.68% -17,264.94% 0.00% - -53,098.78%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 - 0.07 0.05 0.05 - 0.02
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 - 0.86 0.94 1.09 - 0.44
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 0.00 0.00 -9.16 -13 -28 -40 -1.36 7.05 -7.29 -2.61
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 - -0.86 -3.81 -6.88 - -0.39
Increase / (Decrease) in Invested Capital		 0.00 0.00 0.00 -9.16 -13 0.00 -40 7.80 21 21 38
Enterprise Value (EV)		 0.00 0.00 0.00 604 219 - 125 -323 37 - 2,233
Market Capitalization		 210 210 210 175 581 - 334 163 415 - 2,802
Book Value per Share		 $0.00 $0.00 $0.00 ($89.69) $6.40 $4.78 $3.09 $8.92 $3.70 $2.89 $4.46
Tangible Book Value per Share		 $0.00 $0.00 $0.00 ($89.69) $6.40 $4.78 $3.09 $7.98 $3.21 $2.40 $4.06
Total Capital		 0.00 0.00 0.00 200 348 260 168 485 385 301 567
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 0.00 0.00 0.00 -210 -362 -288 -209 -487 -378 -309 -570
Capital Expenditures (CapEx)		 0.00 2.17 0.16 0.00 0.78 0.37 0.04 0.62 0.00 0.00 0.16
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.00 0.00 -18 -18 -33 -44 -55 -50 -64 -62
Debt-free Net Working Capital (DFNWC)		 0.00 0.00 0.00 191 344 255 165 432 328 245 462
Net Working Capital (NWC)		 0.00 0.00 0.00 191 344 255 165 432 328 245 462
Net Nonoperating Expense (NNE)		 9.95 13 17 17 24 26 28 -224 30 25 24
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 -210 -362 -288 -209 -487 -378 -309 -570
Total Depreciation and Amortization (D&A)		 0.00 0.32 0.76 0.00 0.81 0.82 0.84 0.87 0.92 0.87 0.87
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% - -251.13% -272.77% -225.35% - -732.28%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% - 949.34% 2,153.99% 1,482.18% - 5,492.78%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% - 949.34% 2,153.99% 1,482.18% - 5,492.78%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 ($46.20) ($1.73) $35.48 ($1.82) $0.78 ($1.06) ($0.76) ($0.74)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 4.89M 53.75M 28.34M 54.28M 76.48M 104.11M 85.03M 125.05M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($46.20) ($1.73) $35.48 ($1.82) $0.77 ($1.06) ($0.75) ($0.74)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 4.89M 53.75M 28.34M 54.28M 76.64M 104.11M 85.03M 125.05M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 54.40M 54.41M 54.41M 54.41M 104.06M 104.39M 127.20M 127.49M
Normalized Net Operating Profit after Tax (NOPAT)		 -26 -31 -33 -39 -69 -69 -71 -98 -81 -68 -69
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% - -408.70% -3,690.07% -3,906.31% - -3,956.71%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% - -569.11% 1,903.98% -5,360.70% - -5,344.80%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.78% -0.01% - 0.00%

Financials Breakdown Chart

Key Financial Trends

Alumis (NASDAQ: ALMS) continues to look like a development-stage biotech that is still deeply unprofitable, but it ended Q1 2026 with a very strong cash position after a major equity raise. The latest quarter showed minimal revenue, sizable operating losses, and ongoing cash burn, but the balance sheet now gives the company more breathing room than it had a year ago.

  • Cash and equivalents plus investments totaled about $569.6 million at the end of Q1 2026, giving Alumis a much larger liquidity cushion.
  • The company raised $323.8 million from common equity issuance in Q1 2026, which significantly strengthened the balance sheet.
  • Net cash used in operations improved from -$106.4 million in Q2 2025 to -$87.1 million in Q1 2026, suggesting a modest reduction in quarterly burn.
  • Total current assets of $532.4 million versus current liabilities of $70.9 million point to a solid near-term liquidity position.
  • Interest and investment income of $5.3 million helped offset some of the operating loss in Q1 2026.
  • Quarterly revenue remained very small at $1.7 million, so the company is still far from meaningful commercial scale.
  • Research and development expense remained high at $81.5 million in Q1 2026, consistent with a pipeline-heavy biotech model.
  • Shares outstanding remain elevated after financing activity, which can dilute existing shareholders over time.
  • Alumis posted a $93.1 million net loss in Q1 2026, extending a long pattern of substantial quarterly losses.
  • Operating cash flow was still deeply negative at -$87.1 million, showing that the business continues to consume cash despite the capital raise.

Longer-term trend: Alumis has moved from a much smaller, loss-making base in 2024 to a much more capitalized company in 2025 and 2026, largely because of financing, not because of revenue growth. Revenue has stayed in the low single-digit millions per quarter, while operating expenses have remained extremely high due to research and development.

Bottom line: The latest quarter is better viewed as a balance-sheet story than an operating-performance story. Alumis has enough cash to keep advancing its pipeline for now, but investors should expect continued losses and dilution risk until the company can produce meaningful clinical or commercial progress.

07/19/26 07:34 PM ETAI Generated. May Contain Errors.

Alumis Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Alumis' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Alumis' net income appears to be on an upward trend, with a most recent value of -$243.33 million in 2025, rising from -$154.99 million in 2023. The previous period was -$294.23 million in 2024. View Alumis' forecast to see where analysts expect Alumis to go next.

Alumis' total operating income in 2025 was -$453.80 million, based on the following breakdown:
  • Total Gross Profit: $24.05 million
  • Total Operating Expenses: $477.85 million

Over the last 2 years, Alumis' total revenue changed from $0.00 in 2023 to $24.05 million in 2025, a change of 2,405,000,000.0%.

Alumis' total liabilities were at $110.64 million at the end of 2025, a 36.8% increase from 2024, and a 106.8% increase since 2023.

In the past 2 years, Alumis' cash and equivalents has ranged from $46.00 million in 2023 to $169.53 million in 2024, and is currently $89.67 million as of their latest financial filing in 2025.

Over the last 2 years, Alumis' book value per share changed from -157.78 in 2023 to 2.89 in 2025, a change of -101.8%.


Related Companies

Financial statements for NASDAQ:ALMS last updated on 5/19/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel
“The unseen winner of the AI race” is not SpaceX
Marc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...
Chaikin Analytics | Sponsoredtc pixel
BlackRock, JPMorgan, and Goldman are all stock piling the same asset… are you?
BlackRock, JPMorgan, Goldman Sachs, Fidelity, ARK Invest and Andreessen Horowitz are all buying the same asset...
Awesomely | Sponsoredtc pixel